News
MEDIA INQUIRIES
Please contact Colleen O’Malley, Sr. Director, Marketing & Communications, ABTA at 773-577-8750.
ABTA Press Releases
ABTA SURVEY FINDS DISPARITIES IN CARE OF PATIENTS WITH METASTATIC BRAIN TUMORS
A first-of-its-kind, cross-sectional survey of patients, caregivers and physicians on the diagnosis and treatment of brain metastases, conducted by the American Brain Tumor Association (ABTA), as part of its Metastatic Brain Tumor Initiative, revealed disparities in practice patterns and communication around metastatic brain tumors. These data highlight the need to increase accessibility to clinical trials, establish clear standards of care and improve physician-patient communication reflective of the unique needs of patients with brain metastases (BM). The survey results have been published open access in the journal Neuro-Oncology Practice.
ABTA Awards 11 Research Grants to Advance Brain Tumor Research
The American Brain Tumor Association (ABTA) persists in its mission, announcing today the investment of $368,000 towards 11 new research grants to foster innovation in diagnosis and treatment of brain tumors in adults and children.
A Statement of Unity
American Brain Tumor Association (ABTA) today announced a new partnership with the Southeastern Brain Tumor Foundation (SBTF) to accelerate brain tumor research. Through this partnership, the Southeastern Brain Tumor Foundation will invest $50,000 in the ABTA research program to fund one glioblastoma immunotherapy research project.
American Brain Tumor Association and Southeastern Brain Tumor Foundation Announce Partnership to Accelerate Brain Tumor Research
American Brain Tumor Association (ABTA) today announced a new partnership with the Southeastern Brain Tumor Foundation (SBTF) to accelerate brain tumor research. Through this partnership, the Southeastern Brain Tumor Foundation will invest $50,000 in the ABTA research program to fund one glioblastoma immunotherapy research project.
Print 
